However, these results support the notion that AF1q is a co-factor through modification of the promoter binding affinity of transcriptional complex of TCF7/LEF1/Δ-catenin, which promotes higher transcriptional rates in cancer cells. The gene discussed is MLLT11; the disease is cancer.